Table 2.
Baseline clinical and biological parameters of study subjects.
| Parameters | Total (n = 114) |
Obese group (n = 63) |
Nonobese group (n = 51) |
P valuea |
|---|---|---|---|---|
| Age (years) | 13.5 ± 1.6 | 13.5 ± 1.6 | 13.4 ± 1.7 | 0.835 |
| BMI (kg/m2) | 24.5 ± 5.4 | 28.5 ± 2.7 | 19.6 ± 3.6 | <0.0001 |
| SBP (mmHg) | 119.7 ± 9.1 | 122.6 ± 9.6 | 116.2 ± 7.0 | 0.001 |
| DBP (mmHg) | 66.9 ± 8.9 | 71.0 ± 8.9 | 61.9 ± 5.7 | <0.0001 |
| HOMA index | 1.8 ± 0.55 | 1.9 ± 0.64 | 1.6 ± 0.31 | 0.001 |
| TG (mg/dL) | 113.3 ± 25.6 | 128.7 ± 22.9 | 94.3 ± 13.1 | <0.0001 |
| LDL-C (mg/dL) | 94.6 ± 27.5 | 111.9 ± 24.1 | 73.3 ± 12.5 | <0.0001 |
| T-C (mg/dL) | 160.1 ± 27.8 | 177.6 ± 24.3 | 138.6 ± 12.4 | <0.0001 |
| HDL-C (mg/dL) | 44.6 ± 5.9 | 40.7 ± 3.4 | 49.4 ± 4.8 | <0.0001 |
| 25(OH)D (ng/mL) | 26.9 ± 7.4 | 22.5 ± 5.7 | 32.3 ± 5.8 | <0.0001 |
| Adiponectin (μg/mL) | 4.5 ± 1.7 | 3.3 ± 0.89 | 6.0 ± 1.4 | <0.0001 |
| Fasting glucose (mg/dL) | 85.2 ± 12.8 | 89.0 ± 15.0 | 80.5 ± 7.2 | 0.003 |
a P values between obese and nonobese groups.